Clinical Trials · NCT07235917
A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Regeneron Pharmaceuticals
- Enrollment
- 34
- Start date
- Mar 2026
- Locations
- 11 sites, United States
- Primary endpoint
- Change from the highest serum estradiol observed during a 28-day period